Intrinsic Value of S&P & Nasdaq Contact Us

CuraScientific Corp CSTF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
5/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

CuraScientific Corp (CSTF) reported total assets of $1.62M and total liabilities of $26.4M for quarter ending 2023-09-30, resulting in total equity of $-24.78M.

The company held $40.91K in cash and short-term investments. Total debt stood at $733.93K, with net debt of $693.02K. The Debt-to-Equity (D/E) ratio was -0.03 (conservative).

Current ratio is 0.04, which may signal tight short-term liquidity. Interest coverage is -5.7x (weak).

Criteria supported by this page:

  • HEALTH (0/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
  • MOAT (0/100) — Total assets $1.62M and equity $-24.78M support the company's competitive scale

Overall SharesGrow Score: 5/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
5/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
0/100
→ Income
HEALTH
0/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
0/100
Proven by this page
GROWTH
15/100
→ Income
INCOME
10/100
→ Income
CuraScientific Corp Balance Sheet History
Metric Q3 FY2023 Q2 FY2023 Q1 FY2023 Q4 FY2022
Total Assets $1.62M$1.48M$1.39M$1.55M
Total Liabilities $26.4M$27.36M$71.39M$71.06M
Total Debt $733.93K$588.94K$273.54K$2.64M
Cash & Investments $40.91K$281.73K$502.00$130.00
Total Stockholders Equity $-24.78M$-25.89M$-70.01M$-69.51M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message